The EU has produced an infographic to show how the EU’s Scientific Committees assess risks. It not only shows in a clear and concise way how the Committees function but also provides concrete examples of how their work impacts EU legislation. To download the infographic on Risk Assessment from the ec.europa.eu website
Risk assessment in the EU Read More »
All medicinal products in the EU are subject to a strict testing and assessment of their quality, efficacy and safety before being authorised. Once placed on the market they continue to be monitored to ensure that any aspect which could impact the safety profile of a medicine is detected and assessed and that necessary measures
The latest edition of the Eurohealth Observer includes articles on: connecting the dots: putting big data to work for health systems big data for better outcomes: supporting health care system transformation in Europe the Trump Administration launches health law changes into heavy seas what does Brexit mean for health in the UK To download the
Harnessing big data for health Read More »
The Innov8 technical handbook is a user-friendly resource as part of the Innov8 approach for reviewing national health programmes to leave no one behind. It gives detailed guidance and exercise sheets for each of the 8 steps of analysis that comprise the review process and includes background readings, country examples and analytical activities. For more
The Innov8 approach for reviewing national health programmes Read More »
More than 1 in 4 deaths of children under 5 years of age are attributable to unhealthy environments. Every year, environmental risks – such as indoor and outdoor air pollution, second-hand smoke, unsafe water, lack of sanitation, and inadequate hygiene – take the lives of 1.7 million children under 5 years, according to the WHO.
The cost of a polluted environment: 1.7 million child deaths a year Read More »
National health systems in the EU face common challenges: ageing populations and a rise of chronic diseases leading to growing demand for healthcare; shortages and uneven distribution of health professionals etc. Furthermore, (public) financial resources available for health are constrained. Today’s health systems are in need of reforms to tackle these challenges. New care models,
Strategic investments for the future of healthcare Read More »
European Reference Networks (ERNs) are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases. In 2017 24 thematic ERNs, gathering over 900 highly specialised healthcare units from 26 countries, will begin working together on a wide range of issues, from bone disorders to haematological
900 medical teams to connect across Europe for the benefit of patients Read More »
Although air pollutants are invisible killers, people are increasingly aware and concerned about the quality of the air they breathe. From 31st December 2016 a new National Emissions Ceilings (NEC) Directive became law, which sets stricter limits on the five main pollutants in Europe – sulphur dioxide, ammonia, volatile organic compounds, nitrogen oxide and fine
EU rules to drastically cut air pollution Read More »
EU legislation on quality and safety standards for blood, tissues and cells has been in place for more than a decade and in view of the changing landscape – greater use of technology, more disease outbreaks, and a more connected world – the Commission is going to evaluate whether this legislation has achieved its original objectives,
Evaluation of Blood, Tissues and Cells legislation Read More »
Following a brief pause after the economic crisis, health expenditure is rising again in most OECD countries, yet a considerable part of this health expenditure makes little or no contribution to improving people’s health. In some cases, it even results in worse health outcomes. S0, as this report points out, countries could potentially spend significantly
Tackling Wasteful Spending on Health Read More »
